(Bloomberg) — CureVac NV lost more than half its value in German trading after a preliminary analysis of a large study found its vaccine fell short of the high efficacy bar set by other messenger RNA shots. Hong Kong is planning to shorten quarantine periods for fully vaccinated travelers from most places to seven days from as much as 21 days, so long as they pass an antibody test. Moderna Inc. said the U.S. government exercised an option to buy 200 million more doses of its vaccine, bringing… Source link
Read More »Hong Kong to Shorten Quarantine; CureVac’s Plunge: Virus Update
